481 related articles for article (PubMed ID: 31948471)
21. Molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates.
Hou XH; Song XY; Ma XB; Zhang SY; Zhang JQ
Braz J Microbiol; 2015; 46(3):759-68. PubMed ID: 26413058
[TBL] [Abstract][Full Text] [Related]
22. Klebsiella pneumoniae and Klebsiella quasipneumoniae define the population structure of blaKPC-2Klebsiella: a 5 year retrospective genomic study in Singapore.
Octavia S; Kalisvar M; Venkatachalam I; Ng OT; Xu W; Sridatta PSR; Ong YF; Wang L; Chua A; Cheng B; Lin RTP; Teo JWP
J Antimicrob Chemother; 2019 Nov; 74(11):3205-3210. PubMed ID: 31504571
[TBL] [Abstract][Full Text] [Related]
23. Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections in Wuhan, China.
Liu C; Liu L; Jin MM; Hu YB; Cai X; Wan L; Zhang HY; Li RY; Wu XJ
Curr Med Sci; 2022 Feb; 42(1):68-76. PubMed ID: 34985611
[TBL] [Abstract][Full Text] [Related]
24. Outbreak by Hypermucoviscous
Zhan L; Wang S; Guo Y; Jin Y; Duan J; Hao Z; Lv J; Qi X; Hu L; Chen L; Kreiswirth BN; Zhang R; Pan J; Wang L; Yu F
Front Cell Infect Microbiol; 2017; 7():182. PubMed ID: 28560183
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial Resistance of Hypervirulent
Lee CR; Lee JH; Park KS; Jeon JH; Kim YB; Cha CJ; Jeong BC; Lee SH
Front Cell Infect Microbiol; 2017; 7():483. PubMed ID: 29209595
[No Abstract] [Full Text] [Related]
26. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
[TBL] [Abstract][Full Text] [Related]
27. Large-scale genomic analysis of global Klebsiella pneumoniae plasmids reveals multiple simultaneous clusters of carbapenem-resistant hypervirulent strains.
Spadar A; Perdigão J; Campino S; Clark TG
Genome Med; 2023 Jan; 15(1):3. PubMed ID: 36658655
[TBL] [Abstract][Full Text] [Related]
28. Clones and Clusters of Antimicrobial-Resistant Klebsiella From Southwestern Nigeria.
Afolayan AO; Oaikhena AO; Aboderin AO; Olabisi OF; Amupitan AA; Abiri OV; Ogunleye VO; Odih EE; Adeyemo AT; Adeyemo AT; Obadare TO; Abrudan M; Argimón S; David S; Kekre M; Underwood A; Egwuenu A; Ihekweazu C; Aanensen DM; Okeke IN;
Clin Infect Dis; 2021 Dec; 73(Suppl_4):S308-S315. PubMed ID: 34850837
[TBL] [Abstract][Full Text] [Related]
29. Global surveillance of antimicrobial resistance and hypervirulence in Klebsiella pneumoniae from LMICs: An in-silico approach.
Silvester R; Madhavan A; Kokkat A; Parolla A; B M A; M H; Abdulla MH
Sci Total Environ; 2022 Jan; 802():149859. PubMed ID: 34464800
[TBL] [Abstract][Full Text] [Related]
30. Molecular Characterization of Klebsiella pneumoniae Clinical Isolates Through Whole-Genome Sequencing: A Comprehensive Analysis of Serotypes, Sequence Types, and Antimicrobial and Virulence Genes.
Moses VK; Kandi V; Bharadwaj VG; Suvvari TK; Podaralla E
Cureus; 2024 Apr; 16(4):e58449. PubMed ID: 38765395
[TBL] [Abstract][Full Text] [Related]
31. Isolation and characterization of a sequence type 25 carbapenem-resistant hypervirulent Klebsiella pneumoniae from the mid-south region of China.
Li J; Huang ZY; Yu T; Tao XY; Hu YM; Wang HC; Zou MX
BMC Microbiol; 2019 Sep; 19(1):219. PubMed ID: 31533609
[TBL] [Abstract][Full Text] [Related]
32. Whole Genome Sequencing of Extended Spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae Isolated from Hospitalized Patients in KwaZulu-Natal, South Africa.
Founou RC; Founou LL; Allam M; Ismail A; Essack SY
Sci Rep; 2019 Apr; 9(1):6266. PubMed ID: 31000772
[TBL] [Abstract][Full Text] [Related]
33. The Role of Plasmid and Resistance Gene Acquisition in the Emergence of ST23 Multi-Drug Resistant, Hypervirulent Klebsiella pneumoniae.
Du P; Liu C; Fan S; Baker S; Guo J
Microbiol Spectr; 2022 Apr; 10(2):e0192921. PubMed ID: 35297657
[TBL] [Abstract][Full Text] [Related]
34. Whole genome analysis of hypervirulent Klebsiella pneumoniae isolates from community and hospital acquired bloodstream infection.
Shankar C; Veeraraghavan B; Nabarro LEB; Ravi R; Ragupathi NKD; Rupali P
BMC Microbiol; 2018 Jan; 18(1):6. PubMed ID: 29433440
[TBL] [Abstract][Full Text] [Related]
35. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health.
Holt KE; Wertheim H; Zadoks RN; Baker S; Whitehouse CA; Dance D; Jenney A; Connor TR; Hsu LY; Severin J; Brisse S; Cao H; Wilksch J; Gorrie C; Schultz MB; Edwards DJ; Nguyen KV; Nguyen TV; Dao TT; Mensink M; Minh VL; Nhu NT; Schultsz C; Kuntaman K; Newton PN; Moore CE; Strugnell RA; Thomson NR
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3574-81. PubMed ID: 26100894
[TBL] [Abstract][Full Text] [Related]
36. Molecular epidemiology of virulence and antimicrobial resistance determinants in Klebsiella pneumoniae from hospitalised patients in Kilimanjaro, Tanzania.
Sonda T; Kumburu H; van Zwetselaar M; Alifrangis M; Mmbaga BT; Lund O; Kibiki GS; Aarestrup FM
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1901-1914. PubMed ID: 30030694
[TBL] [Abstract][Full Text] [Related]
37. Population Genomic Analysis of 1,777 Extended-Spectrum Beta-Lactamase-Producing
Long SW; Olsen RJ; Eagar TN; Beres SB; Zhao P; Davis JJ; Brettin T; Xia F; Musser JM
mBio; 2017 May; 8(3):. PubMed ID: 28512093
[No Abstract] [Full Text] [Related]
38. Global emergence of double and multi-carbapenemase producing organisms: epidemiology, clinical significance, and evolutionary benefits on antimicrobial resistance and virulence.
Yuan P-B; Dai L-T; Zhang Q-K; Zhong Y-X; Liu W-T; Yang L; Chen D-Q
Microbiol Spectr; 2024 Jul; 12(7):e0000824. PubMed ID: 38860788
[TBL] [Abstract][Full Text] [Related]
39. Hypervirulent Klebsiella pneumoniae (hypermucoviscous and aerobactin positive) infection over 6 years in the elderly in China: antimicrobial resistance patterns, molecular epidemiology and risk factor.
Liu C; Guo J
Ann Clin Microbiol Antimicrob; 2019 Jan; 18(1):4. PubMed ID: 30665418
[TBL] [Abstract][Full Text] [Related]
40. Genome-based analysis of Carbapenemase-producing
Becker L; Kaase M; Pfeifer Y; Fuchs S; Reuss A; von Laer A; Sin MA; Korte-Berwanger M; Gatermann S; Werner G
Antimicrob Resist Infect Control; 2018; 7():62. PubMed ID: 29744043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
